Discover how the viral Ice Water Hack is reshaping weight loss routines in 2025-backed by metabolic science and the ...

Saving Alternatives and A.I.-Powered Clinical Support TEMPE, ARIZONA / ACCESS Newswire / May 27, 2025 / OnePoint Patient Care, a nationwide leading local hospice pharmacy services provider, is proud ...

Selvita is the first contract research organisation (CRO) to license a Chemical Protein Stability Assay developed and ...

Thalassemia, a group of inherited blood disorders characterized by reduced or abnormal hemoglobin production, continues to ...

Challenges, Innovations, and Hope for the FutureClinical trials are the foundation of modern medicine, guiding the ...

Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc ...

SAN DIEGO, CA / ACCESS Newswire / May 27, 2025 / Bora Biologics, a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, announced a major ...

Live virtual events to explore holistic health, hormone therapy, detox, and more - starting May 27, 2025 TUCKER, GA / ACCESS Newswire / May 27, 2025 / Dr. Zavier Ash, MD, a leader in functional ...

Market LaunchFormycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada 27.05.2025 / 14:30 CET/CESTThe issuer is solely responsible for ...

Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces that ...

Further Validates CryptigensTM as Actionable Targets for Cancer Immunotherapy Montreal, Quebec, & Cambridge, UK, 27 May 2025 – Epitopea, a transatlantic cancer immunotherapy company, and Institute for ...

Ambience's latest AI model reduces coding errors and targets $266 billion in annual administrative waste SAN FRANCISCO, CA / ACCESS Newswire / May 27, 2025 / Ambience Healthcare today announced a ...